VERONICA F LAO

Allopathic & Osteopathic Physicians|Anesthesiology SAN ANTONIO, TX NPI 1558505271

General Payments — all program years on this page

$1,226.31

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 42
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $313.33 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $313.3316

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $313.142
2020 $191.052
2021 $14.191
2022 $173.4110
2023 $221.1911
2024 $313.3316

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1114096143 Regeneron Healthcare Solutions, Inc. $28.74 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135464248 Lilly USA, LLC $16.35 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135474682 Lilly USA, LLC $22.26 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135488482 Lilly USA, LLC $18.12 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135495312 Lilly USA, LLC $20.45 04/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137613788 Takeda Pharmaceuticals U.S.A., Inc. $20.89 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137613792 Takeda Pharmaceuticals U.S.A., Inc. $16.56 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146980874 AIMMUNE THERAPEUTICS, INC. $16.09 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146996238 AIMMUNE THERAPEUTICS, INC. $18.59 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147710896 QOL Medical, LLC $16.35 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147710898 QOL Medical, LLC $17.31 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147710900 QOL Medical, LLC $18.14 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147710902 QOL Medical, LLC $27.90 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153411991 Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.40 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153529825 Salix Pharmaceuticals, a division of Bausch Health US, LLC $20.50 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153633932 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.68 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.